Natural products as multidrug resistance modulators in cancer
Author:
Funder
CSIR
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference189 articles.
1. Nanomedicine therapeutic approaches to overcome cancer drug resistance;Markman;Adv. Drug Deliv. Rev.,2013
2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancer in 185 countries;Bray;Ca - Cancer J. Clin.,2018
3. Different strategies to overcome multidrug resistance in cancer;Saraswathy;Biotechnol. Adv.,2013
4. Nanotechnology approaches for personalized treatment of multidrug resistant cancer;Minko;Adv. Drug Deliv. Rev.,2013
5. Molecular mechanisms of drug resistance and its reversal in cancer;Kartal-Yandim;Crit. Rev. Biotechnol.,2016
Cited by 253 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lathyrane diterpenoids with multidrug resistance reversal activity from the tubers of Euphorbia antiquorum;Phytochemistry;2024-12
2. Amarissinin F and its 16-epimer, two neo-clerodane diterpenoids from Salvia amarissima containing a 5-hydroxy-furan-2(5H)-one with MDR modulatory activity in cancer cells;Journal of Molecular Structure;2024-12
3. Discovery of pyridoquinoxaline-based new P-gp inhibitors as coadjutant against Multi Drug Resistance in cancer;European Journal of Medicinal Chemistry;2024-10
4. Unraveling the pathogenesis of myelosuppression and therapeutic potential of natural products;Phytomedicine;2024-09
5. Curcumin affects the pharmacokinetics of florfenicol by downregulating the expression of breast cancer-resistant protein in poultry;Journal of Applied Poultry Research;2024-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3